An acquired inhibitor to factor X in a pediatric patient with extensive burns

Journal of Pediatric Hematology/Oncology

Volumn 18, Issue 2, 1996, Pages 223-226

  Matsunaga, Alison T ^a   Shafer, Frank E ^b  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

burn; factor X inhibitor

Indexed keywords

BLOOD CLOTTING FACTOR 10 INHIBITOR; BLOOD CLOTTING FACTOR 9 COMPLEX; IMMUNOGLOBULIN; PROTHROMBIN COMPLEX; SULFADIAZINE SILVER; UNCLASSIFIED DRUG; VITAMIN K GROUP;

ARTICLE; BLOOD CLOTTING; BURN; CASE REPORT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD; TOPICAL DRUG ADMINISTRATION;

ANTIGENS; BURNS; CHILD; FACTOR X; HUMANS; MALE;

EID: 0029899712     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199605000-00028     Document Type: Article

References (17)

1. Feinstein DI. Acquired inhibitors of blood coagulation. In: Hoffman R, ed. Hematology: basic principles and practice. New York: Churchill Livingstone, 1991.
2. Bajaj SP, Rapaport SI, Barclay S, Herbst KD. Acquired hypoporthrombinemia due to non neutralizing antibodies to prothrombin: mechanism and management. Blood 1985;65:1538.
3. Stricker RB, Lane PK, Leffert JD, et al. Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves. Blood 1988;4:1375.
4. Bayer WL, Curiel DC, Szeto JLK, Lewis JH. Acquired Factor X deficiency in a Negro boy. Pediatrics 1969;44:1007-9.
5. Bayer WL, Borek D, Chandramohan M, Jenkins DC, Plapp FV. Acquired idiopathic Factor X deficiency [Abstract]. Blood 1982:60(suppl)207A.
6. Edgin R, Metz E, Fromkes J, Beman F. Transient acquired Factor X deficiency with associated defects in platelet aggregation. Am J Med 1980;69:137-9.
7. Graham JB, Barrow EM, Wynne TR. Stuart clotting defect III. An acquired case with complete recovery. In: Brinkhous KM, Nicola PDE, eds. Hemophilia and other hemorrhagic states. Chapel Hill, NC: University of North Carolina Press, 1959:158-65.
8. Henson K, Files JC, Morrison FS. Transient acquired Factor X deficiency: report of the use of activated clotting concentrate to control a life threatening hemorrhage. Am J Med 1989;87:583-585.
9. Hosker JP, Jewell DP. Transient, selective Factor X deficiency and acute liver failure following chest infection treated with erythromycin BP. Postgrad Med J 1983;59:514-5.
10. Peucher FW, van Aken WG, van Mourik JA, Swaak AJG, Sie LH, Statius von Eps LW. Acquired transient Factor X (Stuart factor) deficiency in a patient with mycoplasma pneumonial infection. Scand J Haematol 1979;23:257-64.
11. Stefanini N, Wiggishoff CC. Stuart factor (Factor X) deficiency associated with renal and adrenal insufficiency. Ann Intern Med 1966;64:1285-91.
12. Lankiewicz MW. A unique circulating inhibitor with specificity for coagulation Factor X. Am J Med 1992;93:343.
13. Mulhare PE, Tracy PB, Golden EA, et al. A case of acquired Factor X deficiency with in vivo and in vitro evidence of inhibitor activity directed against Factor X. Am J Clin Pathol 1991;96:196.
14. Feinstein DI. Acquired inhibitors of Factor V. Thromb Haemost 1978;39:663.
15. Nesheim ME, Nichols WL, Cole TK, et al. Isolation and study of an acquired inhibitor of human coagulation Factor V. J Clin Invest 1986;77:405.
16. Leytus S, Chung D, Kisiel W, Kurachi K, Davie E. Characterization of a cDNA coding for human Factor X. Proc Natl Acad Sci USA 1984;81:3699.
17. Furie B, Furie BC. The molecular basis of blood coagulation. Cell 1988;53:505.